X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (410) 410
Book / eBook (42) 42
Book Review (33) 33
Publication (25) 25
Dissertation (14) 14
Patent (12) 12
Newspaper Article (6) 6
Conference Proceeding (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (276) 276
humans (254) 254
oncology (226) 226
female (215) 215
middle aged (197) 197
aged (188) 188
adult (170) 170
male (167) 167
aged, 80 and over (109) 109
treatment outcome (100) 100
antineoplastic combined chemotherapy protocols - therapeutic use (95) 95
chemotherapy (84) 84
cancer (81) 81
antineoplastic combined chemotherapy protocols - adverse effects (65) 65
neoplasms - drug therapy (64) 64
medicine & public health (56) 56
pharmacology & pharmacy (56) 56
care and treatment (54) 54
dose-response relationship, drug (54) 54
drug administration schedule (53) 53
research (52) 52
breast neoplasms - drug therapy (51) 51
antineoplastic agents - therapeutic use (48) 48
paclitaxel (48) 48
maximum tolerated dose (47) 47
pharmacology/toxicology (44) 44
gemcitabine (43) 43
antineoplastic agents - administration & dosage (42) 42
antineoplastic agents - adverse effects (42) 42
deoxycytidine - analogs & derivatives (42) 42
neoplasm staging (41) 41
drug therapy (40) 40
tumors (40) 40
carboplatin (38) 38
lung neoplasms - drug therapy (37) 37
paclitaxel - administration & dosage (37) 37
therapy (37) 37
deoxycytidine - administration & dosage (36) 36
breast neoplasms - pathology (35) 35
carcinoma (35) 35
clinical trials (35) 35
disease-free survival (35) 35
antineoplastic combined chemotherapy protocols - administration & dosage (33) 33
cisplatin (33) 33
hematology, oncology and palliative medicine (33) 33
carboplatin - administration & dosage (32) 32
docetaxel (32) 32
abridged index medicus (31) 31
bevacizumab (31) 31
breast cancer (31) 31
infusions, intravenous (31) 31
trial (31) 31
pharmacokinetics (30) 30
survival (30) 30
antineoplastic agents - pharmacokinetics (29) 29
dosage and administration (29) 29
carcinoma, non-small-cell lung - drug therapy (28) 28
solid tumors (28) 28
metastasis (27) 27
antibodies, monoclonal - administration & dosage (26) 26
survival rate (26) 26
trastuzumab (26) 26
analysis (25) 25
antibodies, monoclonal, humanized (25) 25
antineoplastic agents (25) 25
cell lung-cancer (25) 25
administration, oral (24) 24
cancer research (24) 24
neoplasms - pathology (24) 24
combination (23) 23
patients (23) 23
toxicity (23) 23
animals (22) 22
pancreatic cancer (22) 22
efficacy (21) 21
antimitotic agents (20) 20
camptothecin - analogs & derivatives (20) 20
deoxycytidine - adverse effects (20) 20
pancreatic neoplasms - drug therapy (20) 20
safety (20) 20
survival analysis (20) 20
lung neoplasms - pathology (19) 19
neoplasm metastasis (19) 19
receptor, erbb-2 - metabolism (19) 19
adenocarcinoma - drug therapy (18) 18
cancer therapies (18) 18
follow-up studies (18) 18
randomized-trial (18) 18
topotecan (18) 18
antibodies, monoclonal - adverse effects (17) 17
everolimus (17) 17
kaplan-meier estimate (17) 17
paclitaxel - adverse effects (17) 17
breast neoplasms - metabolism (16) 16
lung neoplasms - mortality (16) 16
taxoids - administration & dosage (16) 16
united states (16) 16
young adult (16) 16
antineoplastic combined chemotherapy protocols - pharmacokinetics (15) 15
disease progression (15) 15
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (11) 11
Robarts - Stacks (10) 10
UTL at Downsview - May be requested (5) 5
UofT at Mississauga - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Earth Sciences (Noranda) - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Engineering & Comp. Sci. - Stacks (2) 2
OISE - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Gerstein Science - Not Returned (1) 1
Law (Bora Laskin) - Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Massey College (Robertson Davies) - Rare Book (1) 1
Robarts - Downsview (1) 1
Robarts - Storage (1) 1
Royal Ontario Museum - Stacks (1) 1
Victoria University E.J. Pratt - Storage (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (484) 484
French (5) 5
German (2) 2
Spanish (2) 2
Chinese (1) 1
Czech (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2008, Volume 26, Issue 14, pp. 2311 - 2319
Journal Article
Investigational New Drugs, ISSN 0167-6997, 10/2017, Volume 35, Issue 5, pp. 669 - 669
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s10637-017-0479-3 
Medicine & Public Health | Pharmacology/Toxicology | Oncology | Solid tumors | Tumors
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2011, Volume 29, Issue 4, pp. 398 - 405
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2010, Volume 28, Issue 13, pp. 2131 - 2136
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2007, Volume 25, Issue 22, pp. 3230 - 3237
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 5/2012, Volume 69, Issue 5, pp. 1229 - 1240
Trastuzumab emtansine (T-DM1) is an antibody–drug conjugate comprising trastuzumab and DM1, a microtubule polymerization inhibitor, covalently bound via a... 
Trastuzumab emtansine | Medicine & Public Health | Cancer Research | Oncology | Antibody–drug conjugate | T-DM1 | Breast cancer | Pharmacology/Toxicology | HER2 | Antibody-drug conjugate | BREAST-CANCER | ONCOLOGY | PHARMACOLOGY & PHARMACY | MBC | Antibodies, Monoclonal, Humanized - therapeutic use | Enzyme-Linked Immunosorbent Assay | Maytansine - analogs & derivatives | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Treatment Outcome | Maytansine - therapeutic use | Breast Neoplasms - drug therapy | Maytansine - pharmacology | Tandem Mass Spectrometry | Antibodies, Monoclonal, Humanized - pharmacokinetics | Breast Neoplasms - pathology | Antibodies, Monoclonal, Humanized - pharmacology | Maytansine - pharmacokinetics | Aged, 80 and over | Chromatography, Liquid | Adult | Female | Aged | Trastuzumab | Care and treatment | Oncology, Experimental | Antibodies | Polymerization | Liquid chromatography | Metastasis | Research | Antineoplastic agents | Chromatography | Viral antibodies | Antimitotic agents | Epidermal growth factor | Drug therapy | Mass spectrometry | Cancer | Index Medicus | Thrombocytopenia | Epidermal growth factor receptors | Liver | Data processing | Mass spectroscopy | Pharmacology | transaminase | ErbB-2 protein | trastuzumab | Immunogenicity | Microtubules | thioethers | Pharmacokinetics | Platelets | Enzyme-linked immunosorbent assay | Toxicology | Original
Journal Article
Seminars in Oncology, ISSN 0093-7754, 08/2005, Volume 32, Issue 6, pp. S1 - S3
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2011, Volume 29, Issue 18, pp. 2582 - 2589
Purpose Sorafenib, an oral multikinase inhibitor, has shown preliminary activity in non-small-cell lung cancer (NSCLC). Patients with advanced NSCLC were... 
MULTICENTER | CARBOPLATIN | SOLID TUMORS | ONCOLOGY | BEVACIZUMAB | INHIBITORS | ANTITUMOR-ACTIVITY | COMBINATION | CARCINOMA | CHEMOTHERAPY | PACLITAXEL | Erlotinib Hydrochloride | Niacinamide - analogs & derivatives | Lung Neoplasms - drug therapy | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Phenylurea Compounds | Benzenesulfonates - administration & dosage | Benzenesulfonates - adverse effects | Bevacizumab | Antibodies, Monoclonal, Humanized | Angiogenesis Inhibitors - administration & dosage | Pyridines - adverse effects | DNA Mutational Analysis | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Quinazolines - administration & dosage | Neoplasm Proteins - genetics | Angiogenesis Inhibitors - adverse effects | Carcinoma, Non-Small-Cell Lung - pathology | Hematologic Diseases - chemically induced | Pyridines - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Genes, erbB-1 | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quinazolines - adverse effects | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Genes, ras | Gastrointestinal Diseases - chemically induced | Index Medicus
Journal Article
Journal Article
Cancer Research, ISSN 0008-5472, 05/2015, Volume 75, Issue 9 Supplement, pp. OT2-1-08 - OT2-1-08
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 7/2014, Volume 74, Issue 1, pp. 125 - 130
Journal Article